Use of phosphoprotein phosphatase related factors for diagnosis and treatment of fertility defects
By detecting the phosphorylation levels of phosphoprotein phosphatase 6 regulatory subunit 3, eukaryotic translation initiation factor 3 subunit C and eukaryotic translation initiation factor 4 gamma 1, the problem of unclear male reproductive function in mammals in the existing technology is solved, and accurate diagnosis and prediction of male fertility defects are achieved.
Patent Information
- Application Number
- CN202510239615.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-02-28
- Publication Date
- 2025-09-05
AI Technical Summary
The existing technology lacks research on the exact function of phosphorylation in mammalian male reproduction, which makes it difficult to effectively detect and predict male fertility defects.
Provides methods for diagnosing and predicting male fertility defects, including gene and protein testing, by detecting the phosphorylation levels of protein phosphatase 6 regulatory subunit 3 (PPP6R3), eukaryotic translation initiation factor 3 subunit C (EIF3C), and eukaryotic translation initiation factor 4 gamma 1 (EIF4G1).
It achieves accurate diagnosis and prediction of male fertility defects, provides corresponding diagnostic methods and kits, and can detect whether S39 of EIF3C and S1217 of EIF4G1 are abnormal, and judge fertility defects.